MARKET

KZIA

KZIA

Kazia Therapeuti
NASDAQ
3.637
+0.037
+1.02%
After Hours: 3.505 -0.132 -3.62% 16:05 05/14 EDT
OPEN
3.550
PREV CLOSE
3.600
HIGH
3.843
LOW
3.540
VOLUME
3.44K
TURNOVER
--
52 WEEK HIGH
79.00
52 WEEK LOW
2.860
MARKET CAP
4.94M
P/E (TTM)
-0.0215
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KZIA last week (0505-0509)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 05/07 12:09
Weekly Report: what happened at KZIA last week (0428-0502)?
Weekly Report · 05/05 10:25
Weekly Report: what happened at KZIA last week (0421-0425)?
Weekly Report · 04/28 10:31
Weekly Report: what happened at KZIA last week (0414-0418)?
Weekly Report · 04/21 10:30
Kazia Therapeutics trading halted, news pending
TipRanks · 04/16 23:50
BRIEF-Kazia Therapeutics-Plans To Change Ratio Of Its Adss To Ordinary Shares To One ADS Representing 500 Ordinary Shares
Reuters · 04/15 13:34
Kazia Therapeutics Announces ADS Ratio Change to Maintain Nasdaq Compliance
TipRanks · 04/15 12:48
More
About KZIA
More
Kazia Therapeutics Limited is an oncology-focused drug development company. The Company operates in the pharmaceutical research and development business. The Company’s lead program is paxalisib, an investigational brain-penetrant inhibitor of the PI3K / Akt / mTOR pathway, which is being developed to treat multiple forms of brain cancer. It is also developing EVT801, a small-molecule inhibitor of VEGFR3, which is critical to the development of new blood vessels and lymphatic vessels in a growing tumor, as well as to the metastasis of tumors to distant sites in the body. It designed paxalisib to inhibit PI3K, a critical control mechanism in growth and cell division, which is activated in many forms of cancer. The Company’s drug candidates are designed to treat diseases, such as brain cancer, renal cancer, and liver cancer.
Recently
Symbol
Price
%Change

Webull offers Kazia Therapeutics Ltd (ADR) stock information, including NASDAQ: KZIA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KZIA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KZIA stock methods without spending real money on the virtual paper trading platform.